Insights into myelodysplastic syndromes from current preclinical models

doi:10.5315/wjh.v5.i1.1

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8323)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

619

WORD

475

HTML

4572

Figures (1-2)

158

Tables (1-3)

270

Sum=6094

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

840

Download

1389

Sum=2229

Feb 6, 2016 (publication date) through Nov 14, 2024

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Hematology

ISSN

2218-6204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Hematol. Feb 6, 2016; 5(1): 1-22
Published online Feb 6, 2016. doi: 10.5315/wjh.v5.i1.1

Full Size Figure Download Figure

Figure 2 Time-line showing key genetic aberrations identified in myelodysplastic syndromes and published mouse models. MDS: Myelodysplastic syndromes.

Citation: Tan SY, Smeets MF, Chalk AM, Nandurkar H, Walkley CR, Purton LE, Wall M. Insights into myelodysplastic syndromes from current preclinical models. World J Hematol 2016; 5(1): 1-22
URL: https://www.wjgnet.com/2218-6204/full/v5/i1/1.htm
DOI: https://dx.doi.org/10.5315/wjh.v5.i1.1